Novartis AG broke ground on its more than 700,000-square-foot flagship manufacturing hub in North Carolina, moving rapidly to construct its recently announced investment in the state. The North Carolina project will include the construction of a new facility in Morrisville and a new site in Durham encompassing two new facilities, as well as the expansion of an existing Novartis facility in Durham. Together, these investments are expected to create 700 new jobs in North Carolina by 2030 and support more than 3,000 indirect jobs across the Novartis US supply chain.
This expansion is a key pillar in the company's $23 billion investment in US-based infrastructure over the next five years. US Food and Drug Administration Commissioner Marty Makary, MD, MPH, North Carolina Governor Josh Stein and other elected officials from the state, joined Novartis leadership and employees and members of the local community to celebrate the official start of construction of the manufacturing hub. With construction now underway, Novartis is strengthening its coast-to-coast manufacturing and research network, enabling full end-to-end manufacturing capabilities across its main therapeutic areas, supporting the delivery of its key medicines to patients across the US at scale.
Anticipated to open in 2027-2028, the company?s flagship manufacturing hub was marked by a formal groundbreaking ceremony at one of the new sites, and photo opportunities to commemorate the occasion.
